INDB:NASDAQIndependent Bank Corp. Analysis
Data as of 2026-05-23 - not real-time
$78.82
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Independent Bank Corp. posted a solid Q1 2026 earnings beat, with net interest income climbing and net income rising to nearly $80 million, while a $124 million share‑repurchase program returned capital to shareholders. Dividend yield remains attractive at over 3 %, supporting income‑focused investors, and the payout ratio sits comfortably below 50 %. Technical indicators are bullish: the price trades above the 20‑day SMA, the MACD line sits above its signal, and the RSI hovers in neutral territory, suggesting room for upside without immediate overbought pressure. Support sits near $75.4 and resistance near $79.5, giving the stock a clear range to test.
Valuation appears compelling, with a DCF‑derived fair value of roughly $182 versus the current price near $79, implying an upside of around 15 %. The bank’s revenue growth exceeds 50 % year‑over‑year, and earnings per share are projected to accelerate, reinforcing a growth‑value blend narrative. Volatility is moderate‑high at roughly 18 % over the past month, but beta is close to market, and liquidity remains stable. Overall, the combination of strong earnings, generous dividend, and significant valuation gap supports a positive outlook across short, medium, and long horizons.
Valuation appears compelling, with a DCF‑derived fair value of roughly $182 versus the current price near $79, implying an upside of around 15 %. The bank’s revenue growth exceeds 50 % year‑over‑year, and earnings per share are projected to accelerate, reinforcing a growth‑value blend narrative. Volatility is moderate‑high at roughly 18 % over the past month, but beta is close to market, and liquidity remains stable. Overall, the combination of strong earnings, generous dividend, and significant valuation gap supports a positive outlook across short, medium, and long horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover
- Price above 20‑day SMA with clear support
- Strong dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue growth and earnings acceleration
- Significant valuation upside to DCF fair value
- Continued share repurchases and dividend sustainability
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term DCF upside exceeding 15 %
- Stable cash flow generation and low leverage
- Consistent dividend policy supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth51.60%
Profit Margin27.46%
P/E Ratio15.7
ROE7.32%
ROA1.08%
P/B Ratio1.1
Op. Cash Flow$355.0M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI55.6
Support$75.39
Resistance$79.46
MA 20$77.69
MA 50$77.20
MA 200$74.29
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$181.70
Target Price$90.57
Upside/Downside14.91%
GradeUndervalued
TypeBlend
Dividend Yield3.25%
Risk Assessment
Beta1.02
Volatility17.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.